Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Fuzheng Injection for COVID-19 pneumonia
ChiCTR2000029780Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Feb 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of shenqi fuzheng injection in coronavirus pneumonia (2 arms), sponsored by Union Hospital. Primary endpoint: Recovery time. Started Feb 2020; status: recruiting.
02
Drugs
shenqi fuzheng injection
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029780.